Live Breaking News & Updates on Jim Heins Katie Gallagher
Stay updated with breaking news from Jim heins katie gallagher. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Share this article WALNUT CREEK, Calif., June 2, 2021 /PRNewswire/ Oncodisc Inc. ( Oncodisc ) today announced that it was acquired by Veris Health Inc ( Veris ), a majority owned digital health subsidiary of PAVmed Inc. ( PAVmed ). Oncodisc Inc. Acquired by PAVmed Digital Health Company Veris Health Inc. Oncodisc, a digital health company with groundbreaking tools to improve personalized cancer care through remote patient monitoring, was founded by experienced physician entrepreneurs, James Mitchell, M.D., who joins Veris as its full-time Chief Medical Officer, and Andrew Thoreson, M.D., who will serve as a Veris consultant. Oncodisc s core technologies include what would be the first intelligent implantable vascular access port with biologic sensors and wireless communication, combined with an oncologist-designed remote digital healthcare platform that provides patients and physicians with new tools to improve outcomes and optimize the delivery of cost-effec ....
PAVmed Receives European CE Mark Certification for its CarpX® Minimally Invasive Carpal Tunnel Device May 25, 2021 09:30 ET | Source: PAVmed Inc. PAVmed Inc. NEW YORK, May 25, 2021 (GLOBE NEWSWIRE) PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical device company, today announced that it has received CE Mark certification for its CarpX ® minimally invasive carpal tunnel device. EU-based Notified Body TÜV Rhineland LGA Products GMBH issued a CE Certificate, effective May 24, 2021, declaring that CarpX conforms to the essential requirements of Medical Device Directive 93/42/EEC. With CE Mark secured, CarpX may now be marketed in CE Mark European countries, which include the European Economic Area (the EU, Norway, Iceland and Lichtenstein), Switzerland, and, until July 1, 2023, the United Kingdom. ....
Initial NYU experience in 99 patients demonstrated EsoCheck and EsoGuard capable of detecting esophageal precancer in chronic heartburn patients . ....
PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical technology company, today announced the appointment of prominent UK-based global industry executive, Debbie White, to its Board of Directors. Ms. White will serve on the Company’s Audit and Compensation Committees. “I am delighted to welcome Debbie White to PAVmed’s Board of Directors,” said Lishan Aklog M.D., PAVmed’s Chairman and Chief Executive Officer. “Debbie has broad business leadership experience, including as a chief executive, financial executive, public company director and strategic consultant, in multiple sectors in Europe and the United States, including the healthcare services, molecular genetics and biopharmaceutical industries. She will provide valuable guidance on strategy, operations, finance and international commercialization as PAVmed transitions to a growth-stage commercial company.” ....
Dr. Jacque Sokolov Joins PAVmed Subsidiary Lucid Diagnostics’ Board of Directors April 29, 2021 09:30 ET | Source: PAVmed Inc. PAVmed Inc. NEW YORK, April 29, 2021 (GLOBE NEWSWIRE) PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (“PAVmed”), a highly differentiated, multi-product, commercial-stage medical technology company, today announced that its major subsidiary Lucid Diagnostics Inc. (“Lucid” or the “Company”) has appointed nationally recognized healthcare executive Jacque J. Sokolov to its Board of Directors (the “Board”). Dr. Sokolov will help establish and serve as the inaugural Chair of the Board’s new Compliance & Quality Committee. He will also serve on Lucid’s Audit and Compensation Committees. “I am delighted to welcome Jacque Sokolov to Lucid’s Board of Directors,” said Lishan Aklog M.D., Lucid’s Executive Chairman and PAVmed’s Chairman and Chief Executive Officer. “Jacque brings remarkab ....